Unibest
中
Sign in
← Back to patent-cliff list

Cevidoplenib

Tier C — Watch / trade

Cevidoplenib

Oscotec Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets：Syk

Indications (approved)：Immune thrombocytopenic purpura, Rheumatoid arthritis

Regional status

US
Phase II
2019-03-20
EU
Phase II
2019-03-20
China
-
Japan
-

Synthetic routes & intermediates1 routes

Originator routes × 0Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OptimisedRoute 1Steps 3 · Total yield 270 mg (SKI-O-703)
SKI-O-703-0013934-20-1SKI-O-703-002112758-40-4SKI-O-703-0031448307-66-1SKI-O-703-0041703788-55-9SKI-O-703-0051703788-56-0SKI-O-703-006338464-55-4API · Cevidoplenib
CodeCAS No.Intermediate
SKI-O-703-0013934-20-1Available2,4-dichloropyrimidine
SKI-O-703-002112758-40-43-methyl-1H-pyrazole-4-carbaldehyde
SKI-O-703-0031448307-66-11-(2-chloropyrimidin-4-yl)-3-methyl-1H-pyrazole-4-carbaldehyde
SKI-O-703-0041703788-55-9(5-amino-1-methyl-1H-indol-3-yl)(cyclopropyl)methanone
SKI-O-703-0051703788-56-01-(2-((3-(cyclopropanecarbonyl)-1-methyl-1H-indol-5-yl)amino)pyrimidin-4-yl)-3-methyl-1H-pyrazole-4-carbaldehyde
SKI-O-703-006338464-55-4(S)-isoxazolidin-4-ol hydrochloride

Frequently asked questions

What are the approved indications of Cevidoplenib?

Approved indications include: Immune thrombocytopenic purpura, Rheumatoid arthritis.

When does the Cevidoplenib patent expire?

No public expiry year is available for Cevidoplenib yet; this page updates once verified.

How many synthesis routes are recorded for Cevidoplenib?

1 synthesis routes are recorded; the shortest is 3 steps with 270 mg (SKI-O-703) total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Cevidoplenib intermediates?

1 intermediate CAS of Cevidoplenib are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Cevidoplenib intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-08